1. Home
  2. PRIM vs RYTM Comparison

PRIM vs RYTM Comparison

Compare PRIM & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primoris Services Corporation

PRIM

Primoris Services Corporation

HOLD

Current Price

$86.66

Market Cap

4.9B

Sector

Industrials

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$108.40

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRIM
RYTM
Founded
1960
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.8B
IPO Year
2006
2017

Fundamental Metrics

Financial Performance
Metric
PRIM
RYTM
Price
$86.66
$108.40
Analyst Decision
Buy
Strong Buy
Analyst Count
15
14
Target Price
$155.20
$131.14
AVG Volume (30 Days)
2.1M
985.9K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
0.19%
N/A
EPS Growth
51.66
28.34
EPS
0.32
N/A
Revenue
N/A
N/A
Revenue This Year
$9.92
$55.34
Revenue Next Year
$8.80
$86.06
P/E Ratio
$279.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$65.00
$74.50
52 Week High
$205.50
$122.20

Technical Indicators

Market Signals
Indicator
PRIM
RYTM
Relative Strength Index (RSI) 38.34 60.84
Support Level $65.00 $98.30
Resistance Level $133.04 $113.03
Average True Range (ATR) 6.81 4.86
MACD 0.41 0.24
Stochastic Oscillator 49.68 63.85

Price Performance

Historical Comparison
PRIM
RYTM

About PRIM Primoris Services Corporation

Primoris Services Corp is a provider of critical infrastructure services operating mainly in the United States and Canada. The company provides a range of construction, maintenance, replacement, and engineering services. The Utilities segment operates throughout the United States and specializes in a range of services, including the construction and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communications systems. The Energy segment operates throughout the United States and Canada and specializes in a range of services that include engineering, procurement, construction, and maintenance services to various industries. The majority of the company's revenue is derived from the Energy segment.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: